GC, HeadSpace
IndustriesPharma & Biopharma
ManufacturerSCION Instruments, Teledyne LABS
Importance of the topic
Residual solvents are volatile organic chemicals that can remain in active pharmaceutical ingredients after synthesis or packaging and pose health hazards. Regulatory frameworks such as USP 467 set strict limits to ensure patient safety and product quality.
Objectives and study overview
This application note describes the implementation of USP 467 procedure A to identify residual solvents at their limit of detection. The study aims to demonstrate the performance of a SCION 456 gas chromatograph with FID and a Teledyne Tekmar HT3 headspace autosampler in compliance with pharmacopeial requirements.
Methodology and used instrumentation
The analysis employed static headspace sampling in 20 mL vials with 6 mL sample volume. Samples and standards were prepared in water and DMSO to target USP solvent limits. Analytical conditions:
- Gas chromatograph: SCION 456 with FID detector
- Headspace autosampler: Teledyne Tekmar HT3
- Column: SCION 624, 30 m × 0.25 mm × 1.4 μm
- Oven program: 40 °C hold 10 min, then 10 °C/min to 240 °C, hold 3 min
- Carrier gas: Helium at 2.2 mL/min
- Headspace incubation: 80 °C for 45 min
Main results and discussion
The method was validated by six replicate analyses of each solvent class. Key findings:
- All Class 1 solvents achieved signal-to-noise ratios above USP thresholds (greater than 5 for 1,1,1-trichloroethane and greater than 3 for others)
- Resolution between critical pair acetonitrile and dichloromethane exceeded 8, well above the required minimum of 1
- Repeatability expressed as RSD was consistently low across solvent classes, averaging 1.4% for all replicates
- Overlay chromatograms showed clear baseline separation and consistent peak responses
Benefits and practical applications of the method
This headspace GC procedure offers high sensitivity and repeatability for trace solvent detection in pharmaceutical QA/QC laboratories. The robust performance simplifies compliance testing and provides reliable data for regulatory submissions.
Future trends and potential applications
Integration with mass spectrometry and automated data processing could expand detection capabilities. High-throughput screening in continuous manufacturing environments and advanced chemometric analysis may further enhance method flexibility and efficiency.
Conclusion
The combination of SCION 456 GC, FID detection and Teledyne Tekmar HT3 headspace sampling fully meets USP 467 procedure A requirements. The method delivers precise, reproducible results for residual solvent identification at trace levels, supporting regulatory compliance and product safety.
Reference
- United States Pharmacopeia USP 467 Procedure A
- SCION Instruments Application Note AN0022
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.